Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Vaxa Technologies Ltd. has 1 pending office action in the Chemistry & Materials technology area. This matter is assigned to a distinct examiner and a distinct art unit. The company's current engagement with the patent office is concentrated in this filing, suggesting a targeted approach to its intellectual property. Practitioners can observe that the prosecution landscape is focused, with limited distribution across different technical groups.
The busiest examiner is SHELLHAMMER, JAMES PAUL, who is responsible for 1 busiest examiner pending action. Since there is 1 pending office action, this examiner is the primary individual for all current prosecution efforts. The distinct art unit indicates that the company's current technical focus is within a specific chemical or material science classification. Practitioners can dedicate their resources to understanding the specific examiner's past actions to navigate the matter.
The involvement of SHELLHAMMER, JAMES PAUL as the busiest examiner means that feedback and requirements originate from this specific source. This structure simplifies the coordination needed to address the busiest examiner pending action. Practitioners can focus their strategy on the specific examination style of the examiner to advance the 1 pending office action toward allowance in the Chemistry & Materials technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHELLHAMMER, JAMES PAUL | 1 | 8.7% | +14.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19240976 | METHOD OF ENHANCING IMMUNE-RESILIENCE OF FISH TO SKIN DISEASES AND SKIN PARASITES | SHELLHAMMER, JAMES PAUL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19240976 | METHOD OF ENHANCING IMMUNE-RESILIENCE OF FISH TO SKIN DISEASES AND SKIN PARASITES | SHELLHAMMER, JAMES PAUL | — |
| Art Unit | Apps |
|---|---|
| 1793 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19240976 | METHOD OF ENHANCING IMMUNE-RESILIENCE OF FISH TO SKIN DISEASES AND SKIN PARASITES | SHELLHAMMER, JAMES PAUL | 1793 | §103 | Non-Final OA | — | Pending | Jun 17, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVaxa Technologies Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
James Paul Shellhammer has the most, with 1 of Vaxa Technologies Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.